News

Articles
About 30% of COVID patients develop “Long COVID,” UCLA research finds
04/22/2022
New UCLA research finds that 30% of people treated for COVID-19 developed Post Acute Sequelae of COVID-19 (PASC), most commonly known as “Long COVID.”

Articles
UCLA-led team creates first comprehensive map of human blood stem cell development
04/14/2022
UCLA scientists and colleagues have created a first-of-its-kind roadmap that traces each step in the development of blood stem cells in the human embryo, providing scientists with a blueprint for producing fully functional blood stem cells in the lab.

Articles
Levels of a certain hormone could predict or detect bone loss in premenopausal women
04/05/2022
Physicians may be able to determine if menopause-related bone loss is already in progress or about to begin by measuring the level of a hormone that declines as women approach their final menstrual period, new UCLA research finds.

Articles
UCLA Neuroscientist Dr. Daniel Geschwind awarded with American Academy of Neurology Cotzias Lecture and Award
03/31/2022
Dr. Daniel Geschwind, a pioneer in the application of systems biology methods in neurologic and psychiatric disease, has been awarded the American Academy of Neurology’s 2022 Cotzias Lecture and Award, the group’s highest honor.

Articles
Researchers say treatment of long COVID could be hampered by lack of consensus in identifying and diagnosing the condition
03/08/2022
In a new report, researchers say the challenges of treating long COVID are amplified by a critical issue: we do not know what constitutes long COVID or how to formally diagnose it, an issue that is further exacerbated by limited research data of varying quality and consistency.

Articles
Jonsson Comprehensive Cancer Center researcher urges caution on AI in mammography
02/25/2022
Analyzing breast-cancer tumors with artificial intelligence has the potential to improve healthcare efficiency and outcomes. But doctors should proceed cautiously, because similar technological leaps previously led to higher rates of false-positive tests and over-treatment.

Articles
Researchers create personalized organoid models for rare spinal cancer
02/18/2022
A new study adds to a growing body of evidence that organoids — lab-grown collections of cells that mimic a patient’s tumor — are a promising avenue for drug discovery to improve outcomes in patients with cancer, particularly rare cancers for which clinical data on drug effectiveness is often lacking.

Articles
MRI-guided radiotherapy appears to lead to fewer side effects from treatment for prostate cancer
02/11/2022
An interim analysis of an ongoing Phase III study from UCLA Jonsson Comprehensive Cancer Center indicates that using magnetic resonance imaging (MRI) to guide precisely-focused high-dose radiation treatment for prostate cancer reduced side effects associated with the treatment.

Articles
Researchers find a heart-brain link in women with generalized anxiety disorder?
02/04/2022
A team of researchers?from?UCLA Health and the Laureate Institute for Brain Research (LIBR) has found a never-before-seen link between the heart and the brain in women with generalized anxiety disorder (GAD), potentially opening a new pathway to treatment.??

Articles
Jonsson Comprehensive Cancer Center meta-analysis may help guide treatment planning for patients with high-risk prostate cancer
01/28/2022
Results of a large study led by UCLA Jonsson Comprehensive Cancer Center researchers could help guide treatment planning for patients with high-risk prostate cancer.